Abstract
The American patent system, made up of three interacting sources (the U.S. Constitution, federal legislation, and interpretative case law), is addressing more and more issues related to medical experimentation. Judicial interpretation of several sections of the Patent Act of 1952, specifically those sections pertaining to patentability, nonobviousness, and the specificity and enablement necessary for a patent to be granted, has led to patent grants for inventions pertaining to the medical and related fields.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsEditor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Rapp Owen, J. (2000). Patent Law and Medical Experimentation. In: Deutsch, E., Taupitz, J. (eds) Forschungsfreiheit und Forschungskontrolle in der Medizin / Freedom and Control of Biomedical Research. Veröffentlichungen des Instituts für Deutsches, Europäisches und Internationales Medizinrecht, Gesundheitsrecht und Bioethik der Universitäten Heidelberg und Mannheim, vol 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57326-2_27
Download citation
DOI: https://doi.org/10.1007/978-3-642-57326-2_27
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-67253-1
Online ISBN: 978-3-642-57326-2
eBook Packages: Springer Book Archive